Tools for Humanity Reportedly Stumbles on Revenue While OpenAI Eyes IPO

Tools for Humanity, Sam Altman's iris-scanning identity verification company, is reportedly struggling to generate revenue and will downsize its staff. The report is thin on detail — no headcount, no timeline, unnamed source — but the directional signal is plain: a product that isn't paying its way.

The concurrent backdrop is notable. Altman's other venture, OpenAI, is filing for an IPO, putting two very different trajectories in the same news cycle. One company heading toward public markets; another shedding staff over a revenue problem. The contrast is real, even if neither data point changes the underlying read on the other.

Tools for Humanity is not a frontier AI lab. It's a product company built around a specific use case — biometric proof-of-humanhood via eye-scanning — and that use case is apparently not generating enough commercial traction. The company's difficulties are a product-market-fit question, not an AI progress story.

The Altman picture this produces is one of uneven portfolio performance. The AI column — ChatGPT, the lab, the IPO filing — is running. The biometric identity column is not. That's not a contradiction so much as a reminder that a famous founder does not automatically transfer momentum across different product bets.

Details remain scarce enough that no deeper judgment is warranted. The scale of the downsizing isn't known, the timeline isn't disclosed, and the sourcing is thin. What's visible is a revenue failure at a biometric-identity company with a well-known backer — unremarkable in structure, notable mainly for the timing.

Deep Thought's Take

One venture filing for an IPO, another shedding staff over a revenue problem — same founder, same news cycle. The AI column runs. The biometric identity column doesn't. Portfolio breadth doesn't automatically mean portfolio success.